COVID-19: Federal & Non-Federal Funding Opportunities

To facilitate COVID-19 research projects, the OVPR has formed a team to identify funding opportunities and other programs to support this work. These opportunities will be shared with the research community on an ongoing basis.

Last updated on August 20, 2021

Jump to: Federal Sources  Non-Federal Sources

Federal

SPONSOR PROGRAM FUNDING DEADLINE
Department of Defense (DoD)

DARPA

DARPA Broad Agency Announcements Not Limited Varies; 4/23/2020 for BTO
Department of Energy (DoE)

Argonne National Laboratory

 

Expedited, Rapid Access Call for COVID-19 Research N/A Ongoing

Department of Health and Human Services (HHS)

AHRQ

Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic Vary with mechanism Applicants should consider this SEN active until 3/15/2023

Department of Health and Human Services (HHS)

CDC

Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States Vary with mechanism 7/16/2023
Department of State (DoS) COVID-19 Small Grants Program Maximum award amount: $100,000 9/30/2020

Food and Drug Administration (FDA)

OMHHE

Innovation Grant: COVID-19 and Health Equity (R01) Clinical Trials Optional Est. up to $1,000,000  
National Institutes of Health (NIH) Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Budgets not limited Application dates: 5/17/2021, 5/17/2022, 5/17/2023
National Institutes of Health (NIH)

AHRQ

Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 Not specified None specified
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs No set limit on budgets Applications accepted on a rolling basis through 8/16/2024
National Institutes of Health (NIH)

NCI

Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis N/A -- allows existing resources to be redirected For the duration of the present crisis
National Institutes of Health (NIH)

NHLBI

Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)   7/6/2024
National Institutes of Health (NIH)

NIA
Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) Vary with mechanism 5/8/2023
National Institutes of Health (NIH)

NIA
Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration Vary with mechanism This notice applies to due dates on or after 6/5/2021 and subsequent receipt dates through 5/7/2023

National Institutes of Health (NIH)

NIAAA

SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)

also

R21 and R03 companion FOAs

Vary with mechanism 8/17/2021
National Institutes of Health (NIH)

NIAID, NIA

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Not limited 5/13/2020; 9/13/2020; and others
National Institutes of Health (NIH)

NIAID

Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) $275,000 (direct costs) 9/9/2020
National Institutes of Health (NIH)

NIAID

Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI) Standard R01 and R21 terms 1/7/2023
National Institutes of Health (NIH)

NIAID

Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Application budgets are not limited Applications accepted on a rolling basis
National Institutes of Health (NIH)

NIAID, NIDA, NIMH

Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide Vary with mechanism Due dates on or after September 7, 2021 and subsequent receipt dates through May 7, 2024

National Institutes of Health (NIH)

NIAMS

Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases Vary with mechanism 11/18/2021

National Institutes of Health (NIH)

NICHD

Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract Vary with mechanism 7/16/2023

National Institutes of Health (NIH)

NICHD

Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic Vary with mechanism 5/8/2023

National Institutes of Health (NIH)

NICHD

Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19 Application budgets are limited to the $150,000/year, direct cost AIDS Application Due Date(s) – September 7, 2021; January 7, 2022; May 7, 2022

National Institutes of Health (NIH)

NICHD

Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities Vary with mechanism Due dates on or after September 8, 2021
National Institutes of Health (NIH)

NIDA

Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection Vary with mechanism 9/7/2024
National Institutes of Health (NIH)

NIDA

Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders Vary with mechanism 9/7/2024
National Institutes of Health (NIH)

NIDA

Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19 Vary with mechanism 9/7/2024
National Institutes of Health (NIH)

NIDA

Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders Vary with mechanism 9/7/2024
National Institutes of Health (NIH)

NIDA

Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) Total funding support (direct costs, indirect costs, fee) normally may not exceed $259,613 for Phase I awards and $1,730,751 for Phase II awards. 8/13/2021
National Institutes of Health (NIH)

NIDCD

 

Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders Vary with mechanism Various application dates on or after 10/5/2020

National Institutes of Health (NIH)

NIDCR

Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) Standard R01 and R21 terms 5/8/2023
National Institutes of Health (NIH)

NIGMS

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 Competitive revision budget is limited to no more than the amount of the current parent award Applications accepted on  a rolling basis from 3/15/2021 to 12/15/2021
National Institutes of Health (NIH)

NIMHD, NIA, NIDA, NCI

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Budget not limited; projects up to 5 years Standard NIH application dates, first date is 10/5/2020

National Institutes of Health (NIH)

NIMHD, NIAMS, NIDA, NIMH, NLM, NCI

Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities Standard R01 budget 5/8/2023
National Institutes of Health (NIH)

OD

Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives   First due dates expected to be in July

National Science Foundation (NSF)

BIO, ENG

Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) Budgets not limited The relevant programs in BIO/MCB and ENG/CBET all accept proposals without deadline. Proposals are reviewed as they are received.

U.S. Department of Agriculture (USDA)

NIFA

Agriculture and Food Research Initiative - Foundational and Applied Science Program Vary with grant type 12/15/2021
USG

PHEMCE

CoronaWatch: COVID-19 MEETING REQUEST FOCUS N/A  

Non-Federal

SPONSOR

PROGRAM

FUNDING

DEADLINE

Notes

Russell Sage Foundation

Pipeline Grants Competition

$30K - $50K

Fall of 2021, exact date TBD

 

Research to improve understanding of the severe consequences of the COVID-19 pandemic, including its economic disruptions, and the mass protests to combat systemic racism and racial inequality in policing and other institutions.

Russell Sage Foundation Social, Political, Economic, and Psychological Consequences of the COVID-19 Pandemic   November 10, 2021  

COVID-19 HPC Consortium

The COVID-19 High Performance Computing (HPC) Consortium

 

Applications page

Not specified

None specified

Applications for computational resources on  supercomputers around the world, software, services, and technical expertise to help COVID-19 researchers.

Robert Wood Johnson Foundation

Pioneering Ideas: Exploring the Future to Build a Culture of Health

The average Pioneer grant in 2019 was $315,031. However, there is not an explicit range for budget requests. Grant periods are flexible, though generally range from 1 to 3 years.

Open

Proposals that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work.

March of Dimes Foundation

Research Grants in maternal and child health

$200K to $300K

9/10/2021

Pregnancy-related disorders and developmental origins of infant health and maternal morbidity and  mortality. May include continued investigations into the effects of COVID-19 infections on maternal and infant health.

Comcast Innovation Fund

Innovation Fund

 

Application page

Up to $150K

Ongoing

COVID-19 effects on the Internet. Research grants and Open Source Development grants.

Pfizer

 

COVID  Vaccine Research:

 

https://www.pfizer.com/purpose/independent-grants/covid-19-vaccine

 

https://www.pfizer.com/purpose/independent-grants

 

Undetermined

 

Ongoing

Studies evaluating COVID burden of disease and sero-epidemiological surveys among specific populations; Epidemiology studies evaluating direct & indirect impact, including modeling approaches, of Pfizer’s vaccine particularly in specific patient populations; Studies measuring the impact of efforts to overcome vaccine hesitancy and enhance vaccine uptake.

Coalition for Epidemic Preparedness Innovations (CEPI)

Global partnership founded in Davos by the governments of Norway and India, the Bill & Melinda Gates Foundation, Wellcome, and the World Economic Forum https://cepi.net/get_involved/cfps

 

Undetermined

Ongoing

Vaccine Drug Products in alternative primary packaging and delivery devices; Sourcing serum or plasma from individuals recovered from infection with SARS-CoV-2 variants for the development of antibody working standards and reference panels; Broadening protection against SARS-COV-2 and new broadly protective Betacoronavirus candidate vaccines; Wellcome Leap Program “R3: RNA Readiness and Response,” jointly funded with CEPI.

Wellcome, the Bill & Melinda Gates Foundation and Mastercard

COVID-19 Therapeutics Accelerator

 

Undetermined

Currently paused, will resume

High risk pre-exposure prophylaxis (e.g. health workers); High risk post-exposure prophylaxis (e.g. close contacts); Mild disease treatment (outpatient); Moderate disease treatment (early hospitalization)

Allen Institute for AI

COVID-19 Open Research Dataset Challenge (CORD-19)  

 

 

$1,000 per task award. More details on prizes and timeline can be found on the discussion post.

 

 

Ongoing

Call to artificial intelligence experts to develop text and data mining tools that can help the medical community develop answers to high priority scientific questions. The CORD-19 dataset represents the most extensive machine-readable coronavirus literature collection available for data mining to date.

Led by the University of North Carolina at Chapel Hill

Rapidly Emerging Antiviral Drug Development Initiative (READDI).

 

Contact READDI here

 

 

Undetermined

Ongoing

Research projects including virologists, medicinal chemists, and drug development experts from academia and industry, with specific expertise in developing antiviral drugs.

Fast – Grants

Fastgrants.org

 

$10K to $500K

Currently paused

 

Scientists at academic institutions currently working on a COVID-19 related project are invited to apply for a Fast Grant; decisions made in under 14 days.

Amazon Web Services (AWS)

Amazon Web Services (AWS) Diagnostic Development Initiative (DDI)

Undetermined

Applications through December 31, 2021, with priority consideration given to applications received before July 31, 2021

$20M commitment to accelerate research in the detection of COVID-19 and other infectious diseases. Funding for early disease detection, diagnostics, prognosis, and public health genomics.

The Mind & Life Institute

Varela Grants

Applicants are required to have attended the Mind & Life Summer Research Institute

 

$20K

August 18 to September 15, 2021

Contemplative science proposals that demonstrate relevance to the current COVID-19 pandemic. For instance, a proposed study may focus on a specific population and how it is being affected by COVID-19.

Contact your Corporate and Foundation Relations representative if you would like to apply/are considering applying for these non-federal funding opportunities.